High FeNO value had a significant impact on the prescription of ICSs in COPD patients, but it did not show a significant association with AE either on its own or with changes in treatment.
Keyphrases
- nitric oxide
- chronic obstructive pulmonary disease
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- liver failure
- cystic fibrosis
- lung function
- hydrogen peroxide
- patient reported outcomes
- nitric oxide synthase
- acute respiratory distress syndrome
- replacement therapy
- patient reported
- smoking cessation